Patent · US Expired

Cyclosporin galenic forms

US7081445B2 · kind B2 · utility

1Cited by

20References

30Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Thomas Cavanak · Biel-Benken, CH
Ulrich Posanski · Glückstadt, DE

Key dates

Filing date	Mar 1, 2004
Grant date	Jul 25, 2006
Priority date	—
Expiry date	Mar 1, 2024

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/44
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.